Zolpidem
Publisher
Springer New York
Reference4 articles.
1. Banerjee, A., García-Oscos, F., Roychowdhury, S., Galindo, L. C., Hall, S., Kilgard, M. P., & Atzori, M. (2012). Impairment of cortical GABAergic synaptic transmission in an environmental rat model of autism. The International Journal of Neuropsychopharmacology, 16(06), 1309–1318.
https://doi.org/10.1017/s1461145712001216
. 2. Chevreuil, C., Polard, E., Gicquel, G., Frémaux, T., & Bentué-Ferrer, D. (2010). Pharmacologic treatment of insomnia in children and adolescent psychiatric patients. Thérapie, 65(1), 1–12.
https://doi.org/10.2515/therapie/2010001
. 3. Han, S., Tai, C., Jones, C. J., Scheuer, T., & Catterall, W. A. (2014). Enhancement of inhibitory neurotransmission by GABA A receptors having α 2,3 -subunits Ameliorates behavioral deficits in a mouse model of autism. Neuron, 81(6), 1282–1289.
https://doi.org/10.1016/j.neuron.2014.01.016
. 4. Zaw, Z. F., & Bates, G. D. L. (1997). Replication of zolpidem test for catatonia in an adolescent. The Lancet, 349(9069), 1914.
https://doi.org/10.1016/s0140-6736(05)63915-3
.
|
|